TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24091902

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Thiopental
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study: 22496199

Group type: EXPERIMENTAL
Intervention: Paroxetine (SSRI), 40 mg maximum daily dosage
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (SNRI), 225 mg maximum daily dosage
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 20920046

Group type: EXPERIMENTAL
Intervention: Continuation of insulin secretagogues
Number of subjects: 964

Group type: COMPARATOR
Intervention: Discontinuation of insulin secretagogues (Control)
Number of subjects: 964
Study: 17656354

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine (0.1%) containing fentanyl (2 microg ml(‐1))
Number of subjects: 28

Group type: COMPARATOR
Intervention: Patient-controlled analgesia with morphine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups on supplemental oxygen
Number of subjects: 28
Study: 16272187

Group type: EXPERIMENTAL
Intervention: Flumazenil (2mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flumazenil (3mg)
Number of subjects: 6
Study: 11403537

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Higher doses of H(2)-receptor antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Misoprostol (low-dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPIs
Number of subjects: 0
Study: 9552953

Group type: EXPERIMENTAL
Intervention: READER method of critical appraisal
Number of subjects: 243

Group type: COMPARATOR
Intervention: Free appraisal
Number of subjects: 243
Study: 7846931

Group type: EXPERIMENTAL
Intervention: Biphasic waveform
Number of subjects: 33

Group type: COMPARATOR
Intervention: Monophasic waveform
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Transvenous anode position in Vena anonyma
Number of subjects: 33

Group type: COMPARATOR
Intervention: Transvenous anode position in Vena cava superior
Number of subjects: 33
Study: 3059850

Group type: EXPERIMENTAL
Intervention: Open challenge with a large dose (3 g/kg) of candy bar sucrose
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Double-blind challenge test utilizing lemon-flavored slushes of sucrose, honey, tapioca starch, or aspartame
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (during double-blind challenge)
Number of subjects: 16
Study: 4590669

Group type: EXPERIMENTAL
Intervention: Fenoprofen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31640636

Group type: EXPERIMENTAL
Intervention: Sleep restriction (going to bed 1 hour later than usual for 7 nights)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sleep extension (going to bed 1 hour earlier than usual for 7 nights)
Number of subjects: 110
Study: 27017207

Group type: EXPERIMENTAL
Intervention: TAP-144-SR (6M) 22.5 mg
Number of subjects: 167

Group type: COMPARATOR
Intervention: TAP-144-SR (3M) 11.25 mg
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: TAP-144-SR (6M)
Number of subjects: 167

Group type: COMPARATOR
Intervention: TAP-144-SR (3M)
Number of subjects: 167
Study: 27190347

Group type: EXPERIMENTAL
Intervention: High-clearance period (PCS: 23 ± 4 mL/min; IS: 30 ± 5 mL/min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-clearance period (PCS: 12 ± 3 mL/min; IS: 17 ± 4 mL/min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-clearance period
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-clearance period
Number of subjects: 14
Study: 24375969

Group type: EXPERIMENTAL
Intervention: Text messaging-assisted lifestyle weight loss intervention (3 group sessions, 5 coaching calls, daily text messages)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group (brief advice session)
Number of subjects: 123
Study: 22767972

Group type: EXPERIMENTAL
Intervention: Trans-septal suturing
Number of subjects: 697

Group type: COMPARATOR
Intervention: Merocel packing
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 697
Study: 19812469

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MCI-CGIC overall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MCI-CGIC
Number of subjects: 0
Study: 17341532

Group type: EXPERIMENTAL
Intervention: CoQ10 50 mg
Number of subjects: 26
Study: 15105190

Group type: EXPERIMENTAL
Intervention: Tranexamic acid treatment plus moderate acute normovolemic hemodilution (ANH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tranexamic acid treatment (control group)
Number of subjects: 100
Study: 11905977

Group type: EXPERIMENTAL
Intervention: Pressure-reducing cushion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Foam cushion
Number of subjects: 32
Study: 9255857

Group type: EXPERIMENTAL
Intervention: Telephone-administered mood ratings (SIGH-SAD)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Telephone-administered mood ratings (HIGH-SAD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Face-to-face mood ratings (SIGH-SAD)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Face-to-face mood ratings (HIGH-SAD)
Number of subjects: 14
Study: 8101467

Group type: EXPERIMENTAL
Intervention: Levocabastine (twice daily)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sodium cromoglycate (four times daily)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sodium cromoglycate
Number of subjects: 71
Study: 3098484

Group type: EXPERIMENTAL
Intervention: Intravenous PGE1 infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study: 30518682

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose
Number of subjects: 1997
Study: 27450474

Group type: EXPERIMENTAL
Intervention: Intravenous 0.9 mg/kg alteplase plus standard care
Number of subjects: 1948

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 1948
Study: 24435660

Group type: EXPERIMENTAL
Intervention: +1.50‐D executive bifocals
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: +1.50‐D executive bifocals with 3‐Δ base‐in prism
Number of subjects: 135

Group type: COMPARATOR
Intervention: Single‐vision lenses (control)
Number of subjects: 135
Study: 22745245

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily for 12 weeks
Number of subjects: 22
Study: 20332510

Group type: COMPARATOR
Intervention: 2000 trials
Number of subjects: 1135

Group type: COMPARATOR
Intervention: 2006 trials
Number of subjects: 1135
Study: 18971727

Group type: EXPERIMENTAL
Intervention: Topical autologous platelet-rich fibrin
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 20
Study: 17081460

Group type: COMPARATOR
Intervention: Anterior cervical corpectomy with fusion (ACF)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Anterior cervical corpectomy and fusion with preserved posterior vertebral wall (PWCF)
Number of subjects: 84
Study: 12651665

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (250 microg) with clonidine (25 microg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (250 microg) with clonidine (75 microg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Intrathecal morphine (250 microg)
Number of subjects: 81
Study: 10908006

Group type: EXPERIMENTAL
Intervention: Matrix treatment model for methamphetamine abuse
Number of subjects: 169

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 169
Study: 8644689

Group type: EXPERIMENTAL
Intervention: Canola margarine and canola cooking oil
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (second wintering-over group)
Number of subjects: 23
Study: 8516522

Group type: EXPERIMENTAL
Intervention: 40 mg of oral omeprazole
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 20 mg of oral omeprazole
Number of subjects: 103

Group type: COMPARATOR
Intervention: Non-premedicated patients
Number of subjects: 103

Group type: COMPARATOR
Intervention: Premedicated with lorazepam and meperidine
Number of subjects: 103
Study: 3552458

Group type: EXPERIMENTAL
Intervention: 40 mg penbutolol with 6 mg piretanide
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29154619

Group type: EXPERIMENTAL
Intervention: List words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Critical distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complementarity ratio
Number of subjects: 0
Study: 27208120

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei strain Shirota-fermented milk
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo milk
Number of subjects: 47
Study: 23318917

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using a pulsed 810-nm laser (average power 50 mW, peak power 80 W, 1,500 Hz, 120 s, 6 J, and 3.4 J/cm² per point) applied three times a week for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment (same application as LLLT but without energy output)
Number of subjects: 20
Study: 23591663

Group type: EXPERIMENTAL
Intervention: Daily oral nutritional supplement drink containing 1.3 mg of vitamin B2, 1.4 mg of vitamin B6, 1.5 μg of B12, 200 μg of folic acid
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 19054400

Group type: EXPERIMENTAL
Intervention: Classical ketogenic diet
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT) ketogenic diet
Number of subjects: 145
Study: 17301038

Group type: EXPERIMENTAL
Intervention: Behavioral sleep-wake observation (BOS%)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination score
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Polysomnography (subgroup of 48 participants)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Linear regression analysis
Number of subjects: 174
Study: 15130301

Group type: EXPERIMENTAL
Intervention: BOLD navigation (trial group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Routine navigation (control group)
Number of subjects: 58
Study: 11781171

Group type: EXPERIMENTAL
Intervention: Low-cost, interior lead hazard control interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 9442415

Group type: EXPERIMENTAL
Intervention: MUSE up to 1000 micrograms
Number of subjects: 103

Group type: COMPARATOR
Intervention: Intracavernous Alprostadil (Prostavasin) up to 20 micrograms
Number of subjects: 103
Study: 7515649

Group type: EXPERIMENTAL
Intervention: Chlorambucil/prednisone (ChP)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 259

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 259
Study: 2454376

Group type: EXPERIMENTAL
Intervention: Carvedilol (25-50 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 8
Study: 29132880

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice a day) plus aspirin (100 mg once a day)
Number of subjects: 7470

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5 mg twice a day)
Number of subjects: 7470

Group type: COMPARATOR
Intervention: Aspirin (100 mg once a day)
Number of subjects: 7470
Study: 27216406

Group type: EXPERIMENTAL
Intervention: 8 mg betamethasone orally (n=50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 8 mg betamethasone parenterally (n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: All groups (oral, parenteral, control)
Number of subjects: 100
Study: 25131773

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 22572633

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg, p.o.) 24h before administration of radiocontrast agent and hydration (1mg/kg/hN/saline for 12h pre‐ and post‐contrast)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Hydration alone (1mg/kg/hN/saline for 12h pre‐ and post‐contrast)
Number of subjects: 159
Study: 20498270

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Echocardiographic indices (APED, IVMD, OVERLAP)
Number of subjects: 75
Study: 18405150

Group type: EXPERIMENTAL
Intervention: Acupuncture group (body acupuncture, electroacupuncture, auricular acupoint taping and pressing)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Medication group (oral administration of Sibutramine)
Number of subjects: 80
Study: 16522834

Group type: EXPERIMENTAL
Intervention: Single dose of oral azithromycin
Number of subjects: 515

Group type: COMPARATOR
Intervention: Untreated villages (control)
Number of subjects: 515
Study: 14674809

Group type: EXPERIMENTAL
Intervention: Participants communicated a stereotype-relevant story through 4-person chains.
Number of subjects: 3
Study: 10826390

Group type: EXPERIMENTAL
Intervention: Health Maintenance Organization (HMO) option
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard CHAMPUS system
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HMO option
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demonstration areas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Demonstration sites
Number of subjects: 0
Study: 8843511

Group type: EXPERIMENTAL
Intervention: Azelastine (2 mg; b.i.d.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1398498

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 5 mg/kg body wt/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 10 mg/kg body wt/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 15 mg/kg body wt/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 20 mg/kg body wt/day
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (all doses)
Number of subjects: 9
Study: 6337581

Group type: EXPERIMENTAL
Intervention: Active dialysis
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham dialysis
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Active dialysis after sham dialysis
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Active dialysis (second period)
Number of subjects: 19
Study: 31780692

Group type: EXPERIMENTAL
Intervention: Entropic nonclassicality criteria tested via homodyne detection with beam splitting operation.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Entropic nonclassicality criteria with phase randomization.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-mode resource states.
Number of subjects: 0
Study: 30518579

Group type: EXPERIMENTAL
Intervention: Geriatrician-led evidence-based Falls Prevention Clinic
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Clinical management recommendations
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Patient experience
Number of subjects: 188
Study: 27091752

Group type: EXPERIMENTAL
Intervention: Vitamin D (600,000 IU vitamin D3 as intramuscular injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25763201

Group type: EXPERIMENTAL
Intervention: CoQ10 (200 mg/d)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 22507468

Group type: EXPERIMENTAL
Intervention: 4% tetracaine gel (Ametop gel)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 4% liposomal lidocaine gel (LMX4 gel)
Number of subjects: 15

Group type: COMPARATOR
Intervention: EMLA cream (2.5% lidocaine and 2.5% prilocaine) applied for 30 min
Number of subjects: 15

Group type: COMPARATOR
Intervention: EMLA cream (2.5% lidocaine and 2.5% prilocaine) applied for 60 min
Number of subjects: 15
Study: 20678674

Group type: EXPERIMENTAL
Intervention: Triple combination treatment with OM 40 mg + AML 10 mg + HCTZ 25 mg
Number of subjects: 2492

Group type: COMPARATOR
Intervention: Dual combinations (OM 40 mg/AML 10 mg, OM 40 mg/HCTZ 25 mg, AML 10 mg + HCTZ 25 mg)
Number of subjects: 2492

Group type: EXPERIMENTAL
Intervention: Triple combination treatment
Number of subjects: 2492

Group type: COMPARATOR
Intervention: Dual combinations
Number of subjects: 2492

Group type: COMPARATOR
Intervention: All treatment groups
Number of subjects: 2492
Study: 17877520

Group type: EXPERIMENTAL
Intervention: Electronic diary
Number of subjects: 36

Group type: COMPARATOR
Intervention: Paper diary
Number of subjects: 36
Study: 15722295

Group type: EXPERIMENTAL
Intervention: Ketoprofen patch (100 mg) applied once a day for 7 days
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo patch applied once a day for 7 days
Number of subjects: 163
Study: 12230150

Group type: EXPERIMENTAL
Intervention: U.S. children
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Both countries
Number of subjects: 202
Study: 10434823

Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA) as an adjunct to fibreoptic tracheal intubation
Number of subjects: 40
Study: 7577027

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allogeneic blood transfusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfused patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-transfused patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfusions
Number of subjects: 0
Study: 2182407

Group type: EXPERIMENTAL
Intervention: alpha-interferon (alpha-IFN, 10(6) IU in a 3.5% aqueous methylcellulose base) without 1% nonoxynol-9 (−N)
Number of subjects: 21

Group type: COMPARATOR
Intervention: alpha-interferon (alpha-IFN, 10(6) IU in a 3.5% aqueous methylcellulose base) with 1% nonoxynol-9 (+N)
Number of subjects: 21
Study: 6260126

Group type: EXPERIMENTAL
Intervention: Tinidazole suppositories
Number of subjects: 192
Study: 31156170

Group type: EXPERIMENTAL
Intervention: Treatment with memantine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of a nursing home/care facility
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severe dementia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mild dementia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At least five comorbidities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No comorbidities
Number of subjects: 0
Study: 28742713

Group type: EXPERIMENTAL
Intervention: EN-EPA (2.2 g EPA/day)
Number of subjects: 191

Group type: COMPARATOR
Intervention: EN-S (isocaloric isonitrogenous standard EN)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 191
Study: 26346765

Group type: EXPERIMENTAL
Intervention: Miniplate only (Group A)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined with single bicortical screw (Group B)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: With more than one bicortical screw (Group C)
Number of subjects: 25
Study: 23426700

Group type: EXPERIMENTAL
Intervention: NSAID
Number of subjects: 57

Group type: COMPARATOR
Intervention: Intra-articular corticosteroid injection
Number of subjects: 57
Study: 21750726

Group type: EXPERIMENTAL
Intervention: Repeated presentations of four types of complex visual scenes in a pseudo-randomized order.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group of subjects who rated the image set as interesting.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjects' motivational disposition.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Image type.
Number of subjects: 0
Study: 19317200

Group type: EXPERIMENTAL
Intervention: Alternative sock systems
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 173
Study: 17027429

Group type: EXPERIMENTAL
Intervention: 5-point frequency format
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-point intensity format
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-point similarity format
Number of subjects: 0

Group type: COMPARATOR
Intervention: Original 'yes/no' format
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-point formats (intensity and frequency)
Number of subjects: 0
Study: 12719078

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily in the evening
Number of subjects: 410

Group type: COMPARATOR
Intervention: Bimatoprost 0.03% once daily in the evening
Number of subjects: 410

Group type: COMPARATOR
Intervention: Travoprost 0.004% once daily in the evening
Number of subjects: 410
Study: 10852765

Group type: EXPERIMENTAL
Intervention: Intravenous GSH 70 mg/kg/d
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravenous GSH 70 mg/kg/d and intravenous NAC 75 mg/kg/d
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (standard septic shock therapy only)
Number of subjects: 30
Study: 9489193

Group type: EXPERIMENTAL
Intervention: Mail-out of a sample sun-protection policy kit
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Mail-out of the policy kit and a follow-up mail-out of a staff development module
Number of subjects: 781
Study: 8258959

Group type: EXPERIMENTAL
Intervention: n-3 PUFA (ethyl esters, EPA+DHA = 7.7 g/day)
Number of subjects: 14
Study: 4042390

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg twice daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo tablets twice daily
Number of subjects: 19
Study: 31522699

Group type: EXPERIMENTAL
Intervention: Harti Hauora Tamariki tool (Harti tool)
Number of subjects: 0
Study: 30009733

Group type: EXPERIMENTAL
Intervention: Early rehabilitation physiotherapy (including limb active/passive activities, respiratory muscle function training, and transcutaneous electrical nerve stimulation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Early rehabilitation physiotherapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 40
Study: 27509605

Group type: EXPERIMENTAL
Intervention: Acupuncture at stellate ganglion combined with intravenous administration of alprostadil (10 µg) and sodium chloride solution (100 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous administration of alprostadil (10 µg) and sodium chloride solution (100 mL)
Number of subjects: 60